Molecular imaging using PET for breast cancer

被引:16
|
作者
Kurihara, Hiroaki [1 ]
Shimizu, Chikako [2 ]
Miyakita, Yasuji [3 ]
Yoshida, Masayuki [4 ]
Hamada, Akinobu [5 ]
Kanayama, Yousuke [6 ]
Yonemori, Kan [2 ]
Hashimoto, Jun [2 ]
Tani, Hitomi [1 ]
Kodaira, Makoto [2 ]
Yunokawa, Mayu [2 ]
Yamamoto, Harukaze [2 ]
Watanabe, Yasuyoshi [6 ]
Fujiwara, Yasuhiro [2 ]
Tamura, Kenji [2 ]
机构
[1] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan
[3] Natl Canc Ctr, Dept Neurosurg, Tokyo 1040045, Japan
[4] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo 1040045, Japan
[5] Natl Canc Ctr, Res Inst, Dept Clin Pharmacol Grp, Translat Res Support Core, Tokyo 104, Japan
[6] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan
关键词
Breast cancer; PET; Molecular imaging; Molecular target therapy; HER2; POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTOR; FDG-PET; WHOLE-BODY; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; F-18-FDG PET; TRASTUZUMAB; TUMOR; EXPRESSION;
D O I
10.1007/s12282-015-0613-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Molecular imaging can visualize the biological processes at the molecular and cellular levels in vivo using certain tracers for specific molecular targets. Molecular imaging of breast cancer can be performed with various imaging modalities, however, positron emission tomography (PET) is a sensitive and non-invasive molecular imaging technology and this review will focus on PET molecular imaging of breast cancer, such as FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 50 条
  • [21] The Clinical Added Value of Breast Cancer Imaging Using Hybrid PET/MR Imaging
    Mainta, Ismini C.
    Sfakianaki, Ilektra
    Shiri, Isaac
    Botsikas, Diomidis
    Garibotto, Valentina
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2023, 31 (04) : 565 - 577
  • [22] Molecular Imaging in Breast Cancer
    van Kruchten, M.
    de Vries, E. G.
    BREAST, 2023, 68 : S2 - S2
  • [23] Molecular imaging of breast cancer
    de Vries, E.
    Munnink, T. Oude
    Nagengast, W.
    Brouwers, A.
    Schroder, C.
    Hospers, G.
    Lub-de Hooge, M.
    van der Wall, E.
    van Diest, P.
    BREAST, 2009, 18 : S8 - S9
  • [24] Molecular Imaging in Breast Cancer
    Daniela Miladinova
    Nuclear Medicine and Molecular Imaging, 2019, 53 : 313 - 319
  • [25] Molecular imaging of breast cancer
    Munnink, T. H. Oude
    Nagengast, W. B.
    Brouwers, A. H.
    Schroder, C. P.
    Hospers, G. A.
    Lub-de Hooge, M. N.
    van der Wall, E.
    van Diest, P. J.
    de Vries, E. G. E.
    BREAST, 2009, 18 : S66 - S73
  • [26] Molecular imaging in breast cancer
    Schuster, DM
    Halkar, RK
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2004, 42 (05) : 885 - +
  • [27] PET, PET/ CT, and PET/ MR Imaging Assessment of Breast Cancer
    Shamim, Shamim Ahmed
    Torigian, Drew A.
    Kumar, Rakesh
    PET CLINICS, 2008, 3 (03) : 381 - +
  • [28] Molecular Imaging in Breast Cancer
    Miladinova, Daniela
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 53 (05) : 313 - 319
  • [29] Molecular Imaging in Breast Cancer
    Ruibal, Alvaro
    Benlloch, Jose Maria
    Olmos, Renato Valdes
    Langstrom, Bengt
    JOURNAL OF ONCOLOGY, 2012, 2012
  • [30] Molecular subtyping of breast cancer by dedicated breast PET
    Sueoka, S.
    Sasada, S.
    Suzuki, E.
    Goda, N.
    Kajitani, K.
    Emi, A.
    Masumoto, N.
    Kadoya, T.
    Haruta, R.
    Kataoka, T.
    Okada, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 65 - 65